Brain-computer interface (BCI) devices are not exclusive to Neuralink, and other companies like New-York based Synchron, are conducting their own clinical trials.
Research provides insight into how gene variants impact early brain development in ASD—and how these four identifiable types may be just the first pieces of the puzzle.
